Skip to content

PP&E (Net) at other companies

Abbott logo
AbbottABT
$12.81B+12.4%
TFX
TeleflexTFX
$476.96M-8.1%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$23.58B+7.4%
Stryker logo
StrykerSYK
$3.96B+6.9%
Haemonetics logo
HaemoneticsHAE
$305.76M+7.6%
CONMED logo
CONMEDCNMD
$110.14M-5.7%

Segments

By geography

See full
U.S.$1.92B
Ireland$750M
Costa Rica$637M

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$68.43B-56.7%
P/E18.6×-44.6×
P/S3.3×-5.3×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's PP&E (net)?
Boston Scientific (BSX) reported PP&E (net) of $4.06B in Q1 2026.
How has Boston Scientific's PP&E (net) changed year-over-year?
Boston Scientific's PP&E (net) increased by 19.9% year-over-year, from $3.39B to $4.06B.
What is the long-term trend for Boston Scientific's PP&E (net)?
Over 5 years (2020 to 2025), Boston Scientific's PP&E (net) has grown at a 14.1% compound annual growth rate (CAGR), from $2.08B to $4.04B.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.